EUVIMEDEUVIMED entdecken
Crossref

Multiple Myeloma Presenting as Autoimmune Hemolytic Anemia: Bortezomib as Potential Therapy for Autoimmune Hemolytic Anemia Refractory to Standard Corticosteroid Therapy

Joehar Hamdan, Ashley Truhlar, Earl H Rudolph, Mahmoud Mahafzah

Clinical Reviews & Cases · 2020

DOI: 10.33425/2689-1069.1019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Reviews & Cases, 2020. Verfasst von Joehar Hamdan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hamdan, J., Truhlar, A., Rudolph, E. H., & Mahafzah, M. (2020). Multiple Myeloma Presenting as Autoimmune Hemolytic Anemia: Bortezomib as Potential Therapy for Autoimmune Hemolytic Anemia Refractory to Standard Corticosteroid Therapy. Clinical Reviews & Cases. https://doi.org/10.33425/2689-1069.1019

Vancouver

Hamdan J, Truhlar A, Rudolph EH, Mahafzah M. Multiple Myeloma Presenting as Autoimmune Hemolytic Anemia: Bortezomib as Potential Therapy for Autoimmune Hemolytic Anemia Refractory to Standard Corticosteroid Therapy. Clinical Reviews & Cases. 2020. doi:10.33425/2689-1069.1019

BibTeX
@article{Hamdan2020,
  author = {Hamdan, Joehar and Truhlar, Ashley and Rudolph, Earl H and Mahafzah, Mahmoud},
  title = {Multiple Myeloma Presenting as Autoimmune Hemolytic Anemia: Bortezomib as Potential Therapy for Autoimmune Hemolytic Anemia Refractory to Standard Corticosteroid Therapy},
  journal = {Clinical Reviews & Cases},
  year = {2020},
  doi = {10.33425/2689-1069.1019}
}
Kostenlos starten →